Business
REM: Portfolio now 63% private, with growth led by Mediclinic and CIVH, and focus on performance
REM: Portfolio now 63% private, with growth led by Mediclinic and CIVH, and focus on performance
About this update from Remgro Limited
Strategic focus has shifted to performance optimization, disciplined capital allocation, and sustainability, with 63% of the portfolio in private assets and a strong Africa-centric approach. Growth drivers include Mediclinic’s transformation and CIVH’s fibre expansion, while portfolio simplification and improved underperforming assets should enhance returns.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.